Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,992 | 774 | 99.8% |
| Education | $22.61 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,299 | 86 | $0 (2024) |
| Novo Nordisk Inc | $1,087 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $942.56 | 51 | $0 (2024) |
| PFIZER INC. | $746.13 | 74 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $743.90 | 44 | $0 (2023) |
| Lilly USA, LLC | $664.07 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $431.95 | 25 | $0 (2024) |
| Antares Pharma, Inc. | $414.25 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $405.19 | 27 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $380.60 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,498 | 83 | ABBVIE INC. ($247.01) |
| 2023 | $1,306 | 79 | ABBVIE INC. ($346.15) |
| 2022 | $1,431 | 97 | ABBVIE INC. ($405.59) |
| 2021 | $1,633 | 110 | AbbVie Inc. ($262.45) |
| 2020 | $647.86 | 38 | SANOFI-AVENTIS U.S. LLC ($216.93) |
| 2019 | $1,335 | 105 | SANOFI-AVENTIS U.S. LLC ($216.84) |
| 2018 | $1,398 | 110 | Novo Nordisk Inc ($207.23) |
| 2017 | $1,766 | 155 | Novo Nordisk Inc ($212.14) |
All Payment Transactions
777 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Obesity | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.97 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Biological | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: PAIN | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/09/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Biological | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Endocrinology | ||||||
| 09/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $24.65 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,935 | 3,931 | $284,608 | $123,439 |
| 2022 | 39 | 2,900 | 4,178 | $287,640 | $77,346 |
| 2021 | 33 | 2,221 | 3,141 | $231,863 | $91,437 |
| 2020 | 40 | 2,721 | 3,802 | $274,373 | $98,775 |
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 383 | $77,749 | $30,042 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 192 | 192 | $39,744 | $23,889 | 60.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 113 | 135 | $38,610 | $16,584 | 43.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 58 | $4,640 | $4,169 | 89.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 64 | $9,216 | $3,812 | 41.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 180 | 204 | $9,384 | $3,358 | 35.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 187 | 187 | $5,423 | $3,304 | 60.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 385 | $4,620 | $3,226 | 69.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 91 | 103 | $8,343 | $2,988 | 35.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 11 | 11 | $2,761 | $2,706 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $5,542 | $2,665 | 48.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 212 | 257 | $7,453 | $2,660 | 35.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 170 | 191 | $6,876 | $2,506 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 220 | $9,143 | $2,189 | 23.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 64 | $2,624 | $1,904 | 72.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,180 | $1,532 | 48.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 75 | 82 | $4,100 | $1,478 | 36.0% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 38 | 50 | $3,800 | $1,369 | 36.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 41 | 54 | $3,780 | $1,366 | 36.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 79 | 92 | $3,772 | $1,360 | 36.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 105 | 140 | $3,640 | $1,333 | 36.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 128 | 149 | $3,129 | $1,134 | 36.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 26 | $4,264 | $1,079 | 25.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 26 | 28 | $4,480 | $978.68 | 21.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 47 | 47 | $2,961 | $889.24 | 30.0% |
About Dr. Anthony Gunn, M.D
Dr. Anthony Gunn, M.D is a Family Medicine healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194718288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Gunn, M.D has received a total of $11,015 in payments from pharmaceutical and medical device companies, with $1,498 received in 2024. These payments were reported across 777 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($10,992).
As a Medicare-enrolled provider, Gunn has provided services to 10,777 Medicare beneficiaries, totaling 15,052 services with total Medicare billing of $390,996. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Independence, MO
- Active Since 08/24/2005
- Last Updated 11/01/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194718288
Products in Payments
- FARXIGA (Drug) $472.11
- UBRELVY (Drug) $469.56
- VRAYLAR (Drug) $418.85
- SOLIQUA 100/33 (Biological) $366.29
- QULIPTA (Drug) $350.93
- Ozempic (Drug) $340.43
- GEMTESA (Drug) $325.64
- TROKENDI XR (Drug) $269.45
- TRULICITY (Drug) $259.93
- CHANTIX (Drug) $254.70
- XYOSTED (Drug) $212.53
- TOUJEO (Drug) $211.27
- TRELEGY ELLIPTA (Drug) $205.16
- Myrbetriq (Drug) $204.75
- BREZTRI (Drug) $195.99
- Vascepa (Drug) $183.00
- Victoza (Drug) $180.07
- JARDIANCE (Drug) $173.09
- Rybelsus (Drug) $161.92
- ENTRESTO (Drug) $153.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Independence
Mark Bowling, Md, MD
Family Medicine — Payments: $10,745
Jason Bergman, Md, MD
Family Medicine — Payments: $10,276
Jennifer Patterson, M.d, M.D
Family Medicine — Payments: $8,262
Dr. James Linnick, D.o, D.O
Family Medicine — Payments: $8,163
Dr. Allison Medlin, M.d, M.D
Family Medicine — Payments: $8,092
Dr. Michael Wells, D.o, D.O
Family Medicine — Payments: $7,953